Discontinuing or Tapering Biologic or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: A Systematic Literature Review.

OBJECTIVES: We aim to review the current state of evidence about tapering or withdrawal of biological (b-) or targeted synthetic (ts-) disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). METHODS: We search the literature for…

Preview only. Read the full abstract at the source